This bill directs the National Cancer Institute to conduct a comprehensive review of stomach cancer in the United States, examining its current incidence, risk factors, screening availability, and public awareness. The review will focus on several key areas including the optimal age for testing and treating H. pylori infection as a prevention strategy, the effectiveness of endoscopic screening and surveillance methods in high-risk populations, and current gaps in awareness and education among both the general public and healthcare providers. The bill specifically calls attention to disparities in stomach cancer incidence and mortality among different racial and ethnic groups. Within 18 months of enactment, the National Cancer Institute Director must submit a report to Congress with recommendations for defining high-risk populations, establishing routine screening guidelines, and improving research and prevention efforts. This legislation aims to address the roughly 27,000 new stomach cancer cases expected annually in the U.S. by strengthening early detection and prevention strategies.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.